首页|马勃药材及饮片质量现状分析

马勃药材及饮片质量现状分析

扫码查看
目的 从性状、鉴别、检查、浸出物等几个方面对马勃药材及其饮片的真伪进行鉴别和质量评价,了解马勃市场质量状况,分析不合格项发生的原因,找出解决问题的办法。方法 以36批马勃样品为考察对象,采用《中国药典》2020年版一部进行检验,对测定结果进行分析。结果 马勃市场质量存在较大问题,36批马勃药材和饮片中有23批不合格,其中7批伪品,8批掺伪,合格率仅为36。1%,不合格项目主要为性状、显微鉴别、总灰分和酸不溶性灰分,不合格原因主要是真伪掺杂。结论 马勃药材和饮片存在较为严重的质量问题,主要为马勃混伪和灰分超标,提示应重点加强该方面的控制。建议规范马勃采收加工修制过程,加强标准执行监督,以确保马勃用药安全有效。
Quality Status and Analysis of Lasiosphaera Calvatia and its Decoction Pieces
OBJECTIVE To identify and evaluate the authenticity and quality of the traditional Chinese medici-nal material,Lasiosphaera Calvatia and its decoction pieces from multiple aspects such as properties,identification,examination,and extracts,in order to understand the quality status of the Lasiosphaera Calvatia market,analyze the causes of non-conforming items,and find solutions to these problems.METHODS 36 batches of Lasiosphaera Cal-vatia samples were analyzed according to the 2020 edition of the Chinese Pharmacopoeia.RESULTS There are sig-nificant quality issues in the Lasiosphaera Calvatia market.Among the 36 batches of the Lasiosphaera Calvatia and its decoction pieces,23 batches were found to be substandard,7 of which were counterfeit and 8 of which were adultera-ted products,with a pass rate of only 36.1%.The primary reason for the non-conformity was the mixture of genuine and falsified products,characterized by their appearance,microscopic identification,total ash content,and acid-insol-uble ash content.CONCLUSION There are serious quality problems in the medicinal materials and decoction pieces of Lasiosphaera Calvatia,mainly due to adulteration and excessive ash content,indicating the need for strengthening focused control in these areas.It is recommended to standardize the process of harvesting,processing,and preparation procedures of Lasiosphaera Calvatia and to strengthen the supervision of standard implementation to ensure the safety and effectiveness of Lasiosphaera Calvatia.

Lasiosphaera CalvatiaQuality Status

江珊、罗干明、徐振球、关倩怡

展开 >

佛山市食品药品检验检测中心,广东佛山 528000

马勃 质量现状

2024

海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
年,卷(期):2024.36(11)